Streetbeat News

Stock Prices

ICE

Intercontinental Exchange (ICE) reported a 33% year-over-year increase in average daily volume for May. This significant growth indicates strong performance and increased market activity.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 12:39 pm

GCTK

Glucotrack has completed its second long-term preclinical study for its continuous blood glucose monitor, showing a mean absolute relative difference of 4.7% at day 90.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 12:38 pm

VIR

Vir Biotechnology shares are trading higher following the announcement of new preliminary data from its Phase 2 SOLSTICE hepatitis delta clinical trial evaluating tobevibart.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 12:37 pm

QQQ

SPY

UUP

The U.S. private sector added 152,000 new jobs in May, falling short of expectations and signaling a potential cooling in the labor market. The ADP National Employment Report showed a decrease from April's 192,000 jobs and missed the market consensus of 173,000. The U.S. Dollar Index (DXY) inched up, while Treasury bond yields held steady. Futures on U.S. equity indices fell during premarket trading.

Portfolio Pulse from Piero Cingari

June 05, 2024 | 12:35 pm

IMNN

IMUNON, Inc. (NASDAQ:IMNN) has announced that the first participants have been vaccinated in its IMNN-101 Phase 1 clinical trial. This study aims to demonstrate the potential of IMUNON's PlaCCine® platform as a next-generation DNA vaccine for seasonal COVID-19.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 12:34 pm

ASML

ASML Holding shares are trading higher following a report suggesting the company will ship its chipmaking machine to Taiwan Semiconductor Manufacturing.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 12:31 pm

ADIL

Adial Pharmaceuticals has dosed the first patient in a pharmacokinetics study of AD04, a treatment for Alcohol Use Disorder. This marks a significant milestone in the development of AD04.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 12:31 pm

HRMY

Harmony Biosciences (NASDAQ:HRMY) reported positive data from its Phase 2 study on pitolisant, showing significant reduction in excessive daytime sleepiness and fatigue in adults with Myotonic dystrophy Type 1.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 12:26 pm

CMPS

CYBN

MNMD

Shares of psychedelics companies are trading lower after an FDA panel rejected the approval of MDMA therapy for PTSD.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 12:26 pm

TSLA

Billionaire investor Ron Baron has expressed strong support for Tesla CEO Elon Musk's $56 billion compensation package, despite scrutiny from proxy advisory firm ISS. Baron emphasized Musk's critical role in Tesla's success, while a Morgan Stanley survey showed majority investor support for the pay package. Tesla shares are trading higher premarket.

Portfolio Pulse from Akanksha Bakshi

June 05, 2024 | 12:25 pm